While we have observed a synergistic upregulation of ADAM17, a failure to observe synergistic downstream effects on MUC5AC could be because enough ADAM17 is already available with HIV infection to mediate its effects on Notch signaling and goblet cell hyperplasia. The gene discussed is MUC5AC; the disease is HIV infectious disease.